1 Min Read
Feb 13 (Reuters) - Redhill Biopharma Ltd
* Redhill biopharma announces enrollment of last patient in bekinda phase iii study for acute gastroenteritis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.